Three-dimensional cell culture: A breakthrough in vivo

International Journal of Molecular Sciences

Volumn 16, Issue 3, 2015, Pages 5517-5527

  Anton, Delphine ^a,b   Burckel, Hélène ^b   Josset, Elodie ^b   Noel, Georges ^a,b  

^a CENTRE PAUL STRAUSS   (France)

^b UNIVERSITÉ DE STRASBOURG   (France)

Author keywords

Cell culture; In vivo; Three dimensional cell culture

Indexed keywords

BIOMIMETIC MATERIAL; MATRIGEL;

ANGIOGENESIS; BIOREACTOR; CELL COMMUNICATION; CELL COUNT; CELL CULTURE; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL VIABILITY; EPITHELIUM CELL; EXPLANT; GENE EXPRESSION; HIGH THROUGHPUT SCREENING; HUMAN; IMMUNE EVASION; IN VIVO CULTURE; MICROCARRIER CULTURE; MULTICELLULAR SPHEROID; NONHUMAN; POLARIZED EPITHELIAL CELL CULTURE; REPRODUCIBILITY; REVIEW; THREE DIMENSIONAL CELL CULTURE; TISSUE ENGINEERING; TISSUE SCAFFOLD; TUMOR MICROENVIRONMENT; ANIMAL; CYTOLOGY; DEVICES; PHYSIOLOGY; PRIMARY CELL CULTURE; PROCEDURES;

ANIMALS; HUMANS; PRIMARY CELL CULTURE; SPHEROIDS, CELLULAR; TISSUE ENGINEERING;

EID: 84925869232     PISSN: 16616596     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms16035517     Document Type: Review

References (28)

1. Hutchinson, L.; Kirk, R. High drug attrition rates—Where are we going wrong? Nat. Rev. Clin. Oncol. 2011, 8, 189–190.
2. Saleh, F.A.; Genever, P.G. Turning round: Multipotent stromal cells, a three-dimensional revolution? Cytotherapy 2011, 13, 903–912.
3. Abbott, A. Cell culture: Biology’s new dimension. Nature 2003, 424, 870–872.
4. Langer, R.; Tirrell, D.A. Designing materials for biology and medicine. Nature 2004, 428, 487–492.
5. Lee, J.; Cuddihy, M.J.; Kotov, N.A. Three-dimensional cell culture matrices: State of the art. Tissue Eng. 2008, 14, 61–86.
6. Smith, S.J.; Wilson, M.; Ward, J.H.; Rahman, C.V.; Peet, A.C.; Macarthur, D.C.; Rose, F.R.; Grundy, R.G.; Rahman, R. Recapitulation of tumor heterogeneity and molecular signatures in a 3D brain cancer model with decreased sensitivity to histone deacetylase inhibition. PLoS One 2012, 7, e52335.
7. Pampaloni, F.; Reynaud, E.G.; Stelzer, E.H. The third dimension bridges the gap between cell culture and live tissue. Nat. Rev. Mol. Cell Biol. 2007, 8, 839–845.
8. Toda, S.; Watanabe, K.; Yokoi, F.; Matsumura, S.; Suzuki, K.; Ootani, A.; Aoki, S.; Koike, N.; Sugihara, H. A new organotypic culture of thyroid tissue maintains three-dimensional follicles with C cells for a long term. Biochem. Biophys. Res. Commun. 2002, 294, 906–911.
9. Aggarwal, B.B.; Danda, D.; Gupta, S.; Gehlot, P. Models for prevention and treatment of cancer: Problems versus promises. Biochem. Pharmacol. 2009, 78, 1083–1094.
10. Hait, W.N. Anticancer drug development: The grand challenges. Nat. Rev. Drug Discov. 2010, 9, 253–254.
11. Steele, V.E.; Lubet, R.A. The use of animal models for cancer chemoprevention drug development. Semin. Oncol. 2010, 37, 327–338.
12. Hsiao, A.Y.; Tung, Y.C.; Qu, X.; Patel, L.R.; Pienta, K.J.; Takayama, S. 384 hanging drop arrays give excellent Z-factors and allow versatile formation of co-culture spheroids. Biotechnol. Bioeng. 2012, 109, 1293–1304.
13. Castaneda, F.; Kinne, R.K. Short exposure to millimolar concentrations of ethanol induces apoptotic cell death in multicellular HepG2 spheroids. J. Cancer Res. Clin. Oncol. 2000, 126, 305–310.
14. MacNeil, S. Progress and opportunities for tissue-engineered skin. Nature 2007, 445, 874–880.
15. Ghosh, M.M.; Boyce, S.; Layton, C.; Freedlander, E.; Mac Neil, S. A comparison of methodologies for the preparation of human epidermal-dermal composites. Ann. Plast. Surg. 1997, 39, 390–404.
16. Griffith, L.G.; Swartz, M.A. Capturing complex 3D tissue physiology in vitro. Nat. Rev. Mol. Cell Biol. 2006, 7, 211–224.
17. Allen, L.T.; Tosetto, M.; Miller, I.S.; O’Connor, D.P.; Penney, S.C.; Lynch, I.; Keenan, A.K.; Pennington, S.R.; Dawson, K.A.; Gallagher, W.M. Surface-induced changes in protein adsorption and implications for cellular phenotypic responses to surface interaction. Biomaterials 2006, 27, 3096–3108.
18. Martin, I.; Wendt, D.; Heberer, M. The role of bioreactors in tissue engineering. Trends Biotechnol. 2004, 22, 80–86.
19. Unsworth, B.R.; Lelkes, P.I. Growing tissues in microgravity. Nat. Med. 1998, 4, 901–907.
20. Sun, T.; Norton, D.; Vickers, N.; McArthur, S.L.; Neil, S.M.; Ryan, A.J.; Haycock, J.W. Development of a bioreactor for evaluating novel nerve conduits. Biotechnol. Bioeng. 2008, 99, 1250–1260.
21. Wendt, D.; Marsano, A.; Jakob, M.; Heberer, M.; Martin, I. Oscillating perfusion of cell suspensions through three-dimensional scaffolds enhances cell seeding efficiency and uniformity. Biotechnol. Bioeng. 2003, 84, 205–214.
22. Demarteau, O.; Jakob, M.; Schafer, D.; Heberer, M.; Martin, I. Development and validation of a bioreactor for physical stimulation of engineered cartilage. Biorheology 2003, 40, 331–336.
23. Rubin, J.; Rubin, C.; Jacobs, C.R. Molecular pathways mediating mechanical signaling in bone. Gene 2006, 367, 1–16.
24. Bokhari, M.; Carnachan, R.J.; Cameron, N.R.; Przyborski, S.A. Culture of HepG2 liver cells on three dimensional polystyrene scaffolds enhances cell structure and function during toxicological challenge. J. Anat. 2007, 211, 567–576.
25. Lin, R.Z.; Chang, H.Y. Recent advances in three-dimensional multicellular spheroid culture for biomedical research. Biotechnol. J. 2008, 3, 1172–1184.
26. Perche, F.; Torchilin, V.P. Cancer cell spheroids as a model to evaluate chemotherapy protocols. Cancer Biol. Ther. 2012, 13, 1205–1213.
27. Chitcholtan, K.; Sykes, P.H.; Evans, J.J. The resistance of intracellular mediators to doxorubicin and cisplatin are distinct in 3D and 2D endometrial cancer. J. Transl. Med. 2012, 10, 38.
28. Bellis, A.D.; Bernade, B.P.; Weiss, M.S.; Shin, S.; Weng, S.; Broadbelt, L.J.; Shea, L.D. Dynamic transcription factor activity profiling in 2D and 3D cell cultures. Biotechnol. Bioeng. 2013, 110, 563–572.